Medical News: KCA: VEGF Inhibitor Shows Promise in Refractory RCC - in Meeting Coverage, KCA from MedPage Today
Links shared publicly online about this topic.
- 1,709total visits
Medical News: KCA: VEGF Inhibitor Shows Promise in Refractory RCC - in Meeting Coverage, KCA from MedPage Today
CHICAGO -- A selective angiogenesis inhibitor achieved stable disease or better response in 95% of patients with treatment-refractory metastatic renal cell cancer in a small phase II study reported he
View full resource at medpagetoday.com
Tags: Kidney Cancer, Renal Cell Carcinoma, Kidney Health, Urinary System, Disease and Condition, News, disease, Medical
Most Recently Shared on October 1, 2009 at 3:06 pm By:
KCA: VEGF Inhibitor Shows Promise in Refractory RCC (CME/CE) http://bit.ly/MO6ox
Advertisement
